HomeBUSINESS
BUSINESS

Asahi Kasei Rolls Out Sanofi’s RA Med Kevzara
(Feb.6.2018)

Asahi Kasei Pharma launched Sanofi’s rheumatoid arthritis (RA) treatment Kevzara (sarilumab) in Japan on February 5 under their license agreement announced in December ...
(LOG IN FOR FULL STORY)